Finally, gain‐ and loss‐of‐function studies were employed to elucidate the role of P53 and the miR‐15a/OGT/EZH2 axis in the progression of HCC, followed by in vivo experiments based on tumour‐bearing nude mice. This evidence concerns the gene EZH2 and neoplasm.